Beclomethasone dipropionate nasal aerosol: Phase III data

In a double-blind, U.S. Phase III trial in 340 patients ages 12 and older, 320 µg/day beclomethasone dipropionate met the primary endpoint of significantly reducing reflective TNSS averaged over the 2...